US Pharma MarketingThe post OCT China 2026: China becoming ‘centre of gravity’ in global clinical trial sector appeared first on Clinical Trials Arena.
OCT China 2026: China becoming ‘centre of gravity’ in global clinical trial sector
At OCT and CTS China 2026, experts discussed how Chinese biotechs are becoming more central to both the clinical trial sector and the dealmaking environment. At OCT and CTS China 2026, experts discussed how Chinese biotechs are becoming more central to the dealmaking environment. Sarah Nightingale, principal consultant at GlobalData. Credit: Arena International Unlock FREE Access to Premium Content Discover exclusive forecasts, analyst insights, and in-depth clinical trials industry analysis across drug development, clinical research, and trial innovation. With a free Clinical Trials Arena profile, you can: Experience unmatched clarity with a single platform that combines unique data, AI, and…
At OCT and CTS China 2026, experts discussed how Chinese biotechs are becoming more central to both the clinical trial sector and the dealmaking environment.
Source: Clinical Trials Arena